UNSW Scientia PhD Scholarships

Offering five scholarships with CSRH researchers

The UNSW Scientia PhD Scholarship Scheme is part of our dedication to harnessing our cutting-edge research to solve complex problems and improve the lives of people in local and global communities. Scientia scholars will have a strong commitment to making a difference in the world with demonstrated potential for contributing to the social engagement and/or global impact pillars of the UNSW 2025 Strategy. The Scientia Scheme is targeted in that applicants will apply to a specific research area with an identified supervisory team and application is by nomination.

  • Work on high quality research projects with the best supervisory teams in world class environments.
  • AUD$41,000 per year stipend for four years.
  • Tuition fees covered for the full four-year period.
  • Coaching and mentoring will form a critical part of your highly personalised leadership development plan.
  • Up to AUD$10,000 each year to build your career and support your international research collaborations.

Further details of the scheme are available from the UNSW Scientia PhD Scholarships site.

To learn more about the strategic research areas being offered by CSRH, please browse below.

If you are interested in applying, please contact the Primary Supervisor listed to discuss the opportunity.

The deadline for applicants to contact supervisors and complete the initial application form is 12 July 2019.

CSRH researcher as primary supervisor

Enhancing hepatitis C testing and treatment among people who inject drugs

Primary CSRH supervisor: Scientia Professor Carla Treloar
Secondary supervisors: Dr Alison Marshall (The Kirby Institute) and Associate Professor Jason Grebely (The Kirby Institute)

Project description
The PhD candidate will be trained to conduct novel, high-quality research integrating social research and epidemiology across NHMRC-funded KI-CSRH studies to improve HCV testing, treatment, and post-treatment care among marginalised populations. The candidate will be responsible for social and epidemiological research from a cohort study evaluating HCV treatment in drug-treatment clinics (ETHOS), a cluster-randomized trial of point-of-care HCV testing to enhance treatment in needle/syringe programmes (TEMPO, funded by SPHERE/Triple-I), and a cohort study of HCV reinfection following treatment (SHARP). These projects are linked to an NHMRC-funded Centre for Research Excellence on Point-of-Care Testing (CIs Grebely/Treloar) offering further training opportunities.

Stigma, health worker attitudes and client outcomes in drug treatment

Primary CSRH supervisor: Dr Loren Brener
Secondary supervisors: Professor William von Hippel (UNSW Psychology) and Associate Professor Joanne Bryant (CSRH) 

Project description
The Australian Institute of Health and Welfare (2018) report into the impact of drug use on the burden of disease, reaffirms the need to reduce harms associated with drug use. Health workers’ attitudes and behaviours are important influences on client health outcomes. For stigmatised groups like drug users, implicit (automatic) and explicit (deliberate) attitudes of health workers may differentially influence their behaviour. Drug users can be challenging to work with, thus regular contact may reinforce stereotypes about them as ‘chaotic’ and ‘unmanageable’. However, medical/disease models of drug use may promote feelings of sympathy for drug users. This project will examine how health workers’ explicit and implicit attitudes differentially influence health outcomes for clients in drug treatment.

CSRH researcher as secondary supervisor

Experiences of HIV diagnosis in the antiretroviral era

Primary supervisor: Associate Professor Garrett Prestage (The Kirby Institute)
Secondary superisors: Associate Professor Limin Mao (CSRH) and Dr Dean Murphy (The Kirby Institute)

Project description
The PhD student will lead academic outputs from an NHMRC Partnership Project investigating experiences of HIV clinical care and community-based support in a cohort of newly diagnosed people across Australia. The aims of the project are to: 1) evaluate policies promoting linkage to HIV care and early initiation of antiretroviral therapy; 2) assess the impact of clinical and community-based support on quality of life and well-being; and 3) investigate the implementation of antiretroviral-based HIV prevention strategies. The student will collect and analyse qualitative data from the current NHMRC project, as well as analyse other data from an extensive archive.

Platform Leadership: The Co-opting of digital platforms in the professions

Primary supervisor: Associate Professor Scott Eacott (UNSW School of Education)
Secondary supervisors: Professor Deborah Lupton (CSRH) and Dr Richard Niesche (UNSW School of Education)

Project description
Technological advances are changing the ways we work giving rise to new organisational forms. Increasingly, the professions are co-opting digital platforms from various public and commercial providers to organise their core activities. This project will research the co-opting of digital platforms in the professions and the social, cultural, political, and temporal implications in the context of contemporary society. Topics could relate to leadership, policy, organisational improvement, among others. Bringing interdisciplinary thinking to the issue of digital platforms and the organising of the professions this research has the dual goals of generating cutting-edge knowledge and real-world impact for a timely issue.

Strengthening China’s rural primary care system through health information systems

Primary supervisor: Dr Maoyi Tian (The George Institute for Global Health)
Secondary supervisors: Associate Professor Limin Mao (CSRH) and Professor David Peiris (The George Institute for Global Health)

Project description
SMARTHealth China seeks to strengthen health information systems to support maximal uptake of the national essential public health services package for hypertension and type 2 diabetes care in rural primary care settings of three diverse regions in China. It will be implemented by China Centre for Disease Control and Prevention (China CDC), and will be conducted in four phases: set up, develop the scalable unit, test of scale up, and go to full scale.